Case Control Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. Jan 16, 2024; 16(1): 11-17
Published online Jan 16, 2024. doi: 10.4253/wjge.v16.i1.11
Table 1 Endoscopy list [n (%)]
Endoscopy
Bolus (n = 80)
TCI (n = 45)
Gastroscopy7 (8.7)3 (6.6)
Colonoscopy18 (22.5)9 (20.0)
Gastro/Colo 30 (37.5)18 (40.0)
EUS20 (25.0)12 (26.7)
ERCP 5 (6.3)3 (6.7)
Table 2 Number and percentage of adverse events [n (%)]

Bolus (n = 80)
TCI (n = 45)
P value
Total adverse events21 (26.0)11 (24.0)0.95
    Hypoxemia3 (14.4)4 (36.4)
    Hypotension10 (47.6)5 (45.4)
    Bradycardia4 (19.0)2 (18.2)
    Tachycardia4 (19.0)0
Table 3 Subgroup analysis according to duration of endoscopy: Short endoscopy < 30 min
Variable (mean ± SD)
Bolus (n = 21)
TCI (n = 10)
Delta
P value
Induction time (min)4.81 ± 1.675.8 ± 1.810.990.11
Total time (min)20.62 ± 6.4921 ± 4.710.380.65
Total dose (mg)198.1 ± 69.19204.4 ± 74.236.30.81
Dose/time (mg/min)10.14 ± 3.259.87 ± 3.580.270.58
Table 4 Subgroup analysis according to duration of endoscopy: Long endoscopy > 60 min
Variable (mean ± SD)
Bolus (n = 13)
TCI (n = 9)
Delta
P value
Induction time (min)6.08 ± 5.159.44 ± 3.503.36< 0.01
Total time (min)73.30 ± 14.2969.89 ± 8.953.410.89
Total dose (mg)656.15 ± 291.42484.67 ± 200.0271.480.27
Dose/time (mg/min)8.94 ± 3.216.82 ± 2.442.120.08